The burgeoning landscape of therapy for obesity and type 2 metabolic disorder is currently witnessing considerable interest surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and GLP-1 https://laytnuqau846930.alltdesign.com/retatrutide-vs-tirzepatide-a-comparative-analysis-57616831